QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Corrigendum to "A high-performance liquid chromatography-tandem mass spectrometry method for the analysis of lifirafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine, and its application in a clinical pharmacokinetic study" [J. Pharm 期刊论文 2019 作者:  Yao Xueting;  Song Ling;  Liu Yang;  Wang Huanhuan;  Liu Jie 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Development of a simple HPLC-MS/MS method to simultaneously determine teriflunomide and its metabolite in human plasma and urine: Application to clinical pharmacokinetic study of teriflunomide sodium and leflunomide 期刊论文 2019, 卷号: 33, 期号: 3, 页码: e4420 作者:  Yao, Xueting;  Liu, Yang;  Song, Ling;  Jiang, Ji;  Xiao, Fei 收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03 HPLC-MS/MS  human plasma and urine  leflunomide  pharmacokinetics  teriflunomide   A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study 期刊论文 2019, 卷号: 166, 页码: 20-29 作者:  Yao, Xueting;  Song, Ling;  Liu, Yang;  Wang, Huanhuan;  Liu, Jie 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 HPLC-MS/MS  Pharmacokinetics  BRAF V600E  EGFR  Lifirafenib   Development of an HPLC-MS/MS method to determine janagliflozin in human plasma and urine: application in clinical study 期刊论文 2018, 卷号: 10, 期号: 17, 页码: 1439-1454 作者:  Song, Ling;  Liu, Yang;  Yao, Xueting;  Liu, Hongzhong;  Chen, Bo 收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03 human plasma and urine  janagliflozin  LC-MS/MS   Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry 期刊论文 2018, 卷号: 157, 页码: 189-200 作者:  Liu, Yang;  Yao, Xueting;  Song, Ling;  Liu, Hongzhong;  Zhao, Qian 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Imigliptin  UHPLC/Q-TOF HRMS  Characterization of metabolites  Metabolic pathways  Human and rat plasma  urine and feces   A high-performance liquid chromatography-tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple-dose pharmacokinetic study 期刊论文 2018, 卷号: 32, 期号: 11, 页码: e4324 作者:  Liu, Yang;  Song, Ling;  Yao, Xueting;  Wu, Yiwen;  Liu, Hongzhong 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Alogliptin  Human plasma and urine  Imigliptin and its metabolites  LC-MS/MS  Pharmacokinetics  T2DM   Simultaneous determination of TPN729 and its five metabolites in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry 期刊论文 2018, 卷号: 151, 页码: 91-105 作者:  Liu, Yang;  Shao, Shuguang;  Song, Hanlin;  Yao, Xueting;  Liu, Jie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 TPN729 and metabolites  Human plasma and urine  LC-MS/MS   Renal Clearable Luminescent WSe2 for Radioprotection of Nontargeted Tissues during Radiotherapy 期刊论文 2017, 卷号: 34, 期号: 6 作者:  Liu, Haixia;  Wang, Junying 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 radiation protection  WSe2  renal clearance  photoluminescence  reactive oxygen species   Black Phosphorus Quantum Dot Induced Oxidative Stress and Toxicity in Living Cells and Mice 期刊论文 2017, 卷号: 9, 期号: 24, 页码: 20399-20409 作者:  Mu Xiaoyu;  Wang Jun-Ying;  Bai Xueting;  Xu Fujuan;  Liu Haixia 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 black phosphorus quantum dots  toxicity  oxidative stress  reactive oxygen species  stability   Ultrasmall WS2 Quantum Dots with Visible Fluorescence for Protection of Cells and Animal Models from Radiation-Induced Damages 期刊论文 2017, 卷号: 3, 期号: 3, 页码: 460-470 作者:  Bai, Xueting;  Wang, Junying;  Mu, Xiaoyu;  Yang, Jiang;  Liu, Haixia 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 WS2 quantum dots  excitation-wavelength dependent fluorescence  radiation protection  renal clearance  reactive oxygen species